Global Bicalutamide Market Insights and Forecast to 2028

Global Bicalutamide Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Bicalutamide Product Introduction
1.2 Market by Type
1.2.1 Global Bicalutamide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Bicalutamide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Single Drug For Prostate Cancer
1.3.3 Combined Chemotherapy For Prostate Cancer
1.3.4 Combined Radiation Therapy Or Castration For Prostate Cancer
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bicalutamide Sales Estimates and Forecasts 2017-2028
2.2 Global Bicalutamide Revenue Estimates and Forecasts 2017-2028
2.3 Global Bicalutamide Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bicalutamide Sales by Region
2.4.1 Global Bicalutamide Sales by Region (2017-2022)
2.4.2 Global Sales Bicalutamide by Region (2023-2028)
2.5 Global Bicalutamide Revenue by Region
2.5.1 Global Bicalutamide Revenue by Region (2017-2022)
2.5.2 Global Bicalutamide Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bicalutamide Sales by Manufacturers
3.1.1 Global Top Bicalutamide Manufacturers by Sales (2017-2022)
3.1.2 Global Bicalutamide Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bicalutamide in 2021
3.2 Global Bicalutamide Revenue by Manufacturers
3.2.1 Global Bicalutamide Revenue by Manufacturers (2017-2022)
3.2.2 Global Bicalutamide Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bicalutamide Revenue in 2021
3.3 Global Bicalutamide Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bicalutamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bicalutamide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bicalutamide Sales by Type
4.1.1 Global Bicalutamide Historical Sales by Type (2017-2022)
4.1.2 Global Bicalutamide Forecasted Sales by Type (2023-2028)
4.1.3 Global Bicalutamide Sales Market Share by Type (2017-2028)
4.2 Global Bicalutamide Revenue by Type
4.2.1 Global Bicalutamide Historical Revenue by Type (2017-2022)
4.2.2 Global Bicalutamide Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bicalutamide Revenue Market Share by Type (2017-2028)
4.3 Global Bicalutamide Price by Type
4.3.1 Global Bicalutamide Price by Type (2017-2022)
4.3.2 Global Bicalutamide Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bicalutamide Sales by Application
5.1.1 Global Bicalutamide Historical Sales by Application (2017-2022)
5.1.2 Global Bicalutamide Forecasted Sales by Application (2023-2028)
5.1.3 Global Bicalutamide Sales Market Share by Application (2017-2028)
5.2 Global Bicalutamide Revenue by Application
5.2.1 Global Bicalutamide Historical Revenue by Application (2017-2022)
5.2.2 Global Bicalutamide Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bicalutamide Revenue Market Share by Application (2017-2028)
5.3 Global Bicalutamide Price by Application
5.3.1 Global Bicalutamide Price by Application (2017-2022)
5.3.2 Global Bicalutamide Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bicalutamide Market Size by Type
6.1.1 North America Bicalutamide Sales by Type (2017-2028)
6.1.2 North America Bicalutamide Revenue by Type (2017-2028)
6.2 North America Bicalutamide Market Size by Application
6.2.1 North America Bicalutamide Sales by Application (2017-2028)
6.2.2 North America Bicalutamide Revenue by Application (2017-2028)
6.3 North America Bicalutamide Market Size by Country
6.3.1 North America Bicalutamide Sales by Country (2017-2028)
6.3.2 North America Bicalutamide Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Bicalutamide Market Size by Type
7.1.1 Europe Bicalutamide Sales by Type (2017-2028)
7.1.2 Europe Bicalutamide Revenue by Type (2017-2028)
7.2 Europe Bicalutamide Market Size by Application
7.2.1 Europe Bicalutamide Sales by Application (2017-2028)
7.2.2 Europe Bicalutamide Revenue by Application (2017-2028)
7.3 Europe Bicalutamide Market Size by Country
7.3.1 Europe Bicalutamide Sales by Country (2017-2028)
7.3.2 Europe Bicalutamide Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bicalutamide Market Size by Type
8.1.1 Asia Pacific Bicalutamide Sales by Type (2017-2028)
8.1.2 Asia Pacific Bicalutamide Revenue by Type (2017-2028)
8.2 Asia Pacific Bicalutamide Market Size by Application
8.2.1 Asia Pacific Bicalutamide Sales by Application (2017-2028)
8.2.2 Asia Pacific Bicalutamide Revenue by Application (2017-2028)
8.3 Asia Pacific Bicalutamide Market Size by Region
8.3.1 Asia Pacific Bicalutamide Sales by Region (2017-2028)
8.3.2 Asia Pacific Bicalutamide Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Bicalutamide Market Size by Type
9.1.1 Latin America Bicalutamide Sales by Type (2017-2028)
9.1.2 Latin America Bicalutamide Revenue by Type (2017-2028)
9.2 Latin America Bicalutamide Market Size by Application
9.2.1 Latin America Bicalutamide Sales by Application (2017-2028)
9.2.2 Latin America Bicalutamide Revenue by Application (2017-2028)
9.3 Latin America Bicalutamide Market Size by Country
9.3.1 Latin America Bicalutamide Sales by Country (2017-2028)
9.3.2 Latin America Bicalutamide Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bicalutamide Market Size by Type
10.1.1 Middle East and Africa Bicalutamide Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bicalutamide Revenue by Type (2017-2028)
10.2 Middle East and Africa Bicalutamide Market Size by Application
10.2.1 Middle East and Africa Bicalutamide Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bicalutamide Revenue by Application (2017-2028)
10.3 Middle East and Africa Bicalutamide Market Size by Country
10.3.1 Middle East and Africa Bicalutamide Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bicalutamide Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 CORDEN PHARMA GMBH
11.2.1 CORDEN PHARMA GMBH Corporation Information
11.2.2 CORDEN PHARMA GMBH Overview
11.2.3 CORDEN PHARMA GMBH Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CORDEN PHARMA GMBH Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CORDEN PHARMA GMBH Recent Developments
11.3 Zeneca GmbH
11.3.1 Zeneca GmbH Corporation Information
11.3.2 Zeneca GmbH Overview
11.3.3 Zeneca GmbH Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Zeneca GmbH Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zeneca GmbH Recent Developments
11.4 Actavis Pharma
11.4.1 Actavis Pharma Corporation Information
11.4.2 Actavis Pharma Overview
11.4.3 Actavis Pharma Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Actavis Pharma Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Actavis Pharma Recent Developments
11.5 Sivem Pharmaceuticals
11.5.1 Sivem Pharmaceuticals Corporation Information
11.5.2 Sivem Pharmaceuticals Overview
11.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sivem Pharmaceuticals Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sivem Pharmaceuticals Recent Developments
11.6 Sorres Pharma
11.6.1 Sorres Pharma Corporation Information
11.6.2 Sorres Pharma Overview
11.6.3 Sorres Pharma Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sorres Pharma Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sorres Pharma Recent Developments
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Corporation Information
11.7.2 Fresenius Kabi Overview
11.7.3 Fresenius Kabi Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Fresenius Kabi Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fresenius Kabi Recent Developments
11.8 ANI Pharmaceuticals
11.8.1 ANI Pharmaceuticals Corporation Information
11.8.2 ANI Pharmaceuticals Overview
11.8.3 ANI Pharmaceuticals Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 ANI Pharmaceuticals Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 ANI Pharmaceuticals Recent Developments
11.9 Accel Pharma
11.9.1 Accel Pharma Corporation Information
11.9.2 Accel Pharma Overview
11.9.3 Accel Pharma Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Accel Pharma Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Accel Pharma Recent Developments
11.10 Apotex Corporation
11.10.1 Apotex Corporation Corporation Information
11.10.2 Apotex Corporation Overview
11.10.3 Apotex Corporation Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Apotex Corporation Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Apotex Corporation Recent Developments
11.11 Shanghai Fudan Fuhua Pharmaceutical
11.11.1 Shanghai Fudan Fuhua Pharmaceutical Corporation Information
11.11.2 Shanghai Fudan Fuhua Pharmaceutical Overview
11.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai Fudan Fuhua Pharmaceutical Recent Developments
11.12 Shanghai Zhaohui Pharmaceutical
11.12.1 Shanghai Zhaohui Pharmaceutical Corporation Information
11.12.2 Shanghai Zhaohui Pharmaceutical Overview
11.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shanghai Zhaohui Pharmaceutical Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shanghai Zhaohui Pharmaceutical Recent Developments
11.13 Zhejiang Haizheng Pharmaceutical
11.13.1 Zhejiang Haizheng Pharmaceutical Corporation Information
11.13.2 Zhejiang Haizheng Pharmaceutical Overview
11.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Zhejiang Haizheng Pharmaceutical Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Zhejiang Haizheng Pharmaceutical Recent Developments
11.14 Shanxi Zhendong Pharmaceutical
11.14.1 Shanxi Zhendong Pharmaceutical Corporation Information
11.14.2 Shanxi Zhendong Pharmaceutical Overview
11.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Shanxi Zhendong Pharmaceutical Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Shanxi Zhendong Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bicalutamide Industry Chain Analysis
12.2 Bicalutamide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bicalutamide Production Mode & Process
12.4 Bicalutamide Sales and Marketing
12.4.1 Bicalutamide Sales Channels
12.4.2 Bicalutamide Distributors
12.5 Bicalutamide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bicalutamide Industry Trends
13.2 Bicalutamide Market Drivers
13.3 Bicalutamide Market Challenges
13.4 Bicalutamide Market Restraints
14 Key Findings in The Global Bicalutamide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Bicalutamide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsule
Table 4. Global Bicalutamide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Bicalutamide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Bicalutamide Sales by Region (2017-2022) & (M Pcs)
Table 7. Global Bicalutamide Sales Market Share by Region (2017-2022)
Table 8. Global Bicalutamide Sales by Region (2023-2028) & (M Pcs)
Table 9. Global Bicalutamide Sales Market Share by Region (2023-2028)
Table 10. Global Bicalutamide Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Bicalutamide Revenue Market Share by Region (2017-2022)
Table 12. Global Bicalutamide Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Bicalutamide Revenue Market Share by Region (2023-2028)
Table 14. Global Bicalutamide Sales by Manufacturers (2017-2022) & (M Pcs)
Table 15. Global Bicalutamide Sales Share by Manufacturers (2017-2022)
Table 16. Global Bicalutamide Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Bicalutamide Revenue Share by Manufacturers (2017-2022)
Table 18. Bicalutamide Price by Manufacturers (2017-2022) &(US$/Pcs)
Table 19. Global Bicalutamide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Bicalutamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bicalutamide as of 2021)
Table 21. Bicalutamide Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Bicalutamide Product Offered
Table 23. Date of Manufacturers Enter into Bicalutamide Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bicalutamide Sales by Type (2017-2022) & (M Pcs)
Table 26. Global Bicalutamide Sales by Type (2023-2028) & (M Pcs)
Table 27. Global Bicalutamide Sales Share by Type (2017-2022)
Table 28. Global Bicalutamide Sales Share by Type (2023-2028)
Table 29. Global Bicalutamide Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Bicalutamide Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Bicalutamide Revenue Share by Type (2017-2022)
Table 32. Global Bicalutamide Revenue Share by Type (2023-2028)
Table 33. Bicalutamide Price by Type (2017-2022) & (US$/Pcs)
Table 34. Global Bicalutamide Price Forecast by Type (2023-2028) & (US$/Pcs)
Table 35. Global Bicalutamide Sales by Application (2017-2022) & (M Pcs)
Table 36. Global Bicalutamide Sales by Application (2023-2028) & (M Pcs)
Table 37. Global Bicalutamide Sales Share by Application (2017-2022)
Table 38. Global Bicalutamide Sales Share by Application (2023-2028)
Table 39. Global Bicalutamide Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Bicalutamide Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Bicalutamide Revenue Share by Application (2017-2022)
Table 42. Global Bicalutamide Revenue Share by Application (2023-2028)
Table 43. Bicalutamide Price by Application (2017-2022) & (US$/Pcs)
Table 44. Global Bicalutamide Price Forecast by Application (2023-2028) & (US$/Pcs)
Table 45. North America Bicalutamide Sales by Type (2017-2022) & (M Pcs)
Table 46. North America Bicalutamide Sales by Type (2023-2028) & (M Pcs)
Table 47. North America Bicalutamide Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Bicalutamide Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Bicalutamide Sales by Application (2017-2022) & (M Pcs)
Table 50. North America Bicalutamide Sales by Application (2023-2028) & (M Pcs)
Table 51. North America Bicalutamide Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Bicalutamide Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Bicalutamide Sales by Country (2017-2022) & (M Pcs)
Table 54. North America Bicalutamide Sales by Country (2023-2028) & (M Pcs)
Table 55. North America Bicalutamide Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Bicalutamide Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Bicalutamide Sales by Type (2017-2022) & (M Pcs)
Table 58. Europe Bicalutamide Sales by Type (2023-2028) & (M Pcs)
Table 59. Europe Bicalutamide Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Bicalutamide Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Bicalutamide Sales by Application (2017-2022) & (M Pcs)
Table 62. Europe Bicalutamide Sales by Application (2023-2028) & (M Pcs)
Table 63. Europe Bicalutamide Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Bicalutamide Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Bicalutamide Sales by Country (2017-2022) & (M Pcs)
Table 66. Europe Bicalutamide Sales by Country (2023-2028) & (M Pcs)
Table 67. Europe Bicalutamide Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Bicalutamide Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Bicalutamide Sales by Type (2017-2022) & (M Pcs)
Table 70. Asia Pacific Bicalutamide Sales by Type (2023-2028) & (M Pcs)
Table 71. Asia Pacific Bicalutamide Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Bicalutamide Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Bicalutamide Sales by Application (2017-2022) & (M Pcs)
Table 74. Asia Pacific Bicalutamide Sales by Application (2023-2028) & (M Pcs)
Table 75. Asia Pacific Bicalutamide Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Bicalutamide Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Bicalutamide Sales by Region (2017-2022) & (M Pcs)
Table 78. Asia Pacific Bicalutamide Sales by Region (2023-2028) & (M Pcs)
Table 79. Asia Pacific Bicalutamide Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Bicalutamide Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Bicalutamide Sales by Type (2017-2022) & (M Pcs)
Table 82. Latin America Bicalutamide Sales by Type (2023-2028) & (M Pcs)
Table 83. Latin America Bicalutamide Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Bicalutamide Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Bicalutamide Sales by Application (2017-2022) & (M Pcs)
Table 86. Latin America Bicalutamide Sales by Application (2023-2028) & (M Pcs)
Table 87. Latin America Bicalutamide Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Bicalutamide Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Bicalutamide Sales by Country (2017-2022) & (M Pcs)
Table 90. Latin America Bicalutamide Sales by Country (2023-2028) & (M Pcs)
Table 91. Latin America Bicalutamide Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Bicalutamide Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Bicalutamide Sales by Type (2017-2022) & (M Pcs)
Table 94. Middle East and Africa Bicalutamide Sales by Type (2023-2028) & (M Pcs)
Table 95. Middle East and Africa Bicalutamide Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Bicalutamide Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Bicalutamide Sales by Application (2017-2022) & (M Pcs)
Table 98. Middle East and Africa Bicalutamide Sales by Application (2023-2028) & (M Pcs)
Table 99. Middle East and Africa Bicalutamide Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Bicalutamide Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Bicalutamide Sales by Country (2017-2022) & (M Pcs)
Table 102. Middle East and Africa Bicalutamide Sales by Country (2023-2028) & (M Pcs)
Table 103. Middle East and Africa Bicalutamide Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Bicalutamide Revenue by Country (2023-2028) & (US$ Million)
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Major Businesses
Table 107. AstraZeneca Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 108. AstraZeneca Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. AstraZeneca Recent Developments
Table 110. CORDEN PHARMA GMBH Corporation Information
Table 111. CORDEN PHARMA GMBH Description and Major Businesses
Table 112. CORDEN PHARMA GMBH Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 113. CORDEN PHARMA GMBH Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. CORDEN PHARMA GMBH Recent Developments
Table 115. Zeneca GmbH Corporation Information
Table 116. Zeneca GmbH Description and Major Businesses
Table 117. Zeneca GmbH Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 118. Zeneca GmbH Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Zeneca GmbH Recent Developments
Table 120. Actavis Pharma Corporation Information
Table 121. Actavis Pharma Description and Major Businesses
Table 122. Actavis Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 123. Actavis Pharma Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Actavis Pharma Recent Developments
Table 125. Sivem Pharmaceuticals Corporation Information
Table 126. Sivem Pharmaceuticals Description and Major Businesses
Table 127. Sivem Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 128. Sivem Pharmaceuticals Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Sivem Pharmaceuticals Recent Developments
Table 130. Sorres Pharma Corporation Information
Table 131. Sorres Pharma Description and Major Businesses
Table 132. Sorres Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 133. Sorres Pharma Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sorres Pharma Recent Developments
Table 135. Fresenius Kabi Corporation Information
Table 136. Fresenius Kabi Description and Major Businesses
Table 137. Fresenius Kabi Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 138. Fresenius Kabi Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Fresenius Kabi Recent Developments
Table 140. ANI Pharmaceuticals Corporation Information
Table 141. ANI Pharmaceuticals Description and Major Businesses
Table 142. ANI Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 143. ANI Pharmaceuticals Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. ANI Pharmaceuticals Recent Developments
Table 145. Accel Pharma Corporation Information
Table 146. Accel Pharma Description and Major Businesses
Table 147. Accel Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 148. Accel Pharma Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Accel Pharma Recent Developments
Table 150. Apotex Corporation Corporation Information
Table 151. Apotex Corporation Description and Major Businesses
Table 152. Apotex Corporation Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 153. Apotex Corporation Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Apotex Corporation Recent Developments
Table 155. Shanghai Fudan Fuhua Pharmaceutical Corporation Information
Table 156. Shanghai Fudan Fuhua Pharmaceutical Description and Major Businesses
Table 157. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 158. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Shanghai Fudan Fuhua Pharmaceutical Recent Developments
Table 160. Shanghai Zhaohui Pharmaceutical Corporation Information
Table 161. Shanghai Zhaohui Pharmaceutical Description and Major Businesses
Table 162. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 163. Shanghai Zhaohui Pharmaceutical Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Shanghai Zhaohui Pharmaceutical Recent Developments
Table 165. Zhejiang Haizheng Pharmaceutical Corporation Information
Table 166. Zhejiang Haizheng Pharmaceutical Description and Major Businesses
Table 167. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 168. Zhejiang Haizheng Pharmaceutical Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Zhejiang Haizheng Pharmaceutical Recent Developments
Table 170. Shanxi Zhendong Pharmaceutical Corporation Information
Table 171. Shanxi Zhendong Pharmaceutical Description and Major Businesses
Table 172. Shanxi Zhendong Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 173. Shanxi Zhendong Pharmaceutical Bicalutamide Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Shanxi Zhendong Pharmaceutical Recent Developments
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Bicalutamide Distributors List
Table 178. Bicalutamide Customers List
Table 179. Bicalutamide Market Trends
Table 180. Bicalutamide Market Drivers
Table 181. Bicalutamide Market Challenges
Table 182. Bicalutamide Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Bicalutamide Product Picture
Figure 3. Global Bicalutamide Market Share by Type in 2021 & 2028
Figure 3. Tablets Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Bicalutamide Market Share by Application in 2021 & 2028
Figure 6. Single Drug For Prostate Cancer
Figure 7. Combined Chemotherapy For Prostate Cancer
Figure 8. Combined Radiation Therapy Or Castration For Prostate Cancer
Figure 9. Bicalutamide Report Years Considered
Figure 10. Global Bicalutamide Sales 2017-2028 (M Pcs)
Figure 11. Global Bicalutamide Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Bicalutamide Revenue 2017-2028 (US$ Million)
Figure 13. Global Bicalutamide Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Bicalutamide Sales Market Share by Region (2017-2022)
Figure 15. Global Bicalutamide Sales Market Share by Region (2023-2028)
Figure 16. North America Bicalutamide Sales YoY (2017-2028) & (M Pcs)
Figure 17. North America Bicalutamide Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Bicalutamide Sales YoY (2017-2028) & (M Pcs)
Figure 19. Europe Bicalutamide Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Bicalutamide Sales YoY (2017-2028) & (M Pcs)
Figure 21. Asia-Pacific Bicalutamide Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Bicalutamide Sales YoY (2017-2028) & (M Pcs)
Figure 23. Latin America Bicalutamide Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Bicalutamide Sales YoY (2017-2028) & (M Pcs)
Figure 25. Middle East & Africa Bicalutamide Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Bicalutamide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Bicalutamide in the World: Market Share by Bicalutamide Revenue in 2021
Figure 28. Global Bicalutamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Bicalutamide Sales Market Share by Type (2017-2028)
Figure 30. Global Bicalutamide Revenue Market Share by Type (2017-2028)
Figure 31. Global Bicalutamide Sales Market Share by Application (2017-2028)
Figure 32. Global Bicalutamide Revenue Market Share by Application (2017-2028)
Figure 33. North America Bicalutamide Sales Market Share by Type (2017-2028)
Figure 34. North America Bicalutamide Revenue Market Share by Type (2017-2028)
Figure 35. North America Bicalutamide Sales Market Share by Application (2017-2028)
Figure 36. North America Bicalutamide Revenue Market Share by Application (2017-2028)
Figure 37. North America Bicalutamide Sales Share by Country (2017-2028)
Figure 38. North America Bicalutamide Revenue Share by Country (2017-2028)
Figure 39. U.S. Bicalutamide Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Bicalutamide Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Bicalutamide Sales Market Share by Type (2017-2028)
Figure 42. Europe Bicalutamide Revenue Market Share by Type (2017-2028)
Figure 43. Europe Bicalutamide Sales Market Share by Application (2017-2028)
Figure 44. Europe Bicalutamide Revenue Market Share by Application (2017-2028)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs